Differences in anti-CREG antibody formation between transplanted and nontransplanted renal patients

Transplantation. 1999 Apr 27;67(8):1188-90. doi: 10.1097/00007890-199904270-00018.

Abstract

Background: The aim of this study was investigation of the HLA-I cross-reactive group (CREG)-specific antibodies (Abs) in sera from patients with a failed renal transplant and from nontransplanted patients.

Methods: A total of 5292 sera from 570 patients awaiting kidney transplantation were screened for the presence of HLA-I CREG-specific Abs. Patients who had never received a transplant (group A), and those with a previous transplant and Abs either not related (group B) or related to donor specificities (group C) were studied. A further division was made for Abs directed against specificities either included in (intra-CREG) or not included in patients' HLA-CREG (extra-CREG).

Results: Twelve of 24 (50%) Abs produced in response to mismatched donor HLA specificities after a failed graft were intra-CREG Abs, compared to 7 of 39 (18%) Abs that were not transplant-related.

Conclusions: Renal grafts showed a stronger immunogenicity than other sources of allosensitization. Our data also suggest that CREG matching may not be useful for renal allocation.

MeSH terms

  • Antibodies / immunology*
  • Antibody Formation
  • HLA Antigens / immunology
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation / immunology*
  • Reoperation
  • Repressor Proteins / immunology*
  • Treatment Failure
  • Waiting Lists

Substances

  • Antibodies
  • CREG1 protein, human
  • HLA Antigens
  • Repressor Proteins